SCHEMBL15823740

SCHEMBL15823740

Cc1c(-c2ccccn2)n[nH]c1N

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LRRK2 Q5S007 1/20 0.51
PIM1 P11309 4/20 0.46
NPC1 O15118 4/20 0.46
KDM4E B2RXH2 3/20 0.46
METAP1 P53582 2/20 0.43
LMNA P02545 1/20 0.43
CYP1A2 P05177 1/20 0.43
POLB P06746 1/20 0.43
CCR1 P32246 1/20 0.43
CCR5 P51681 1/20 0.43
CCR8 P51685 1/20 0.43
BLM P54132 1/20 0.43
HIF1A Q16665 1/20 0.43
DOHH Q9BU89 1/20 0.43
P4HTM Q9NXG6 1/20 0.43
ULK1 O75385 1/20 0.42
CDK7 P50613 1/20 0.42
CDK5 Q00535 1/20 0.42
PRKCE Q02156 1/20 0.42
CAMK2G Q13555 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13184082 0.82 LRRK2 (0.54) LRRK2PIM1NPC1KDM4EMETAP1
SCHEMBL5199282 0.82 LRRK2 (0.54) LRRK2PIM1NPC1KDM4EMETAP1
SCHEMBL29265627 0.79 LRRK2 (0.51) LRRK2PIM1NPC1KDM4EMETAP1
SCHEMBL16068661 0.79 LRRK2 (0.51) LRRK2PIM1NPC1KDM4EMETAP1
Bromide SCHEMBL3499178 0.78 LRRK2 (0.50) LRRK2PIM1NPC1KDM4EMETAP1
SCHEMBL10921085 0.77 KDM4E (0.45) LRRK2NPC1KDM4EMETAP1LMNA
SCHEMBL10991873 0.77 LRRK2 (0.49) LRRK2PIM1NPC1KDM4EMETAP1
SCHEMBL10915208 0.77 LRRK2 (0.49) LRRK2PIM1NPC1KDM4EMETAP1
SCHEMBL19924703 0.77 LRRK2 (0.49) LRRK2PIM1NPC1KDM4EMETAP1
SCHEMBL4005629 0.74 ALDH1A1 (0.53) NPC1KDM4ELMNACYP1A2CDK5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2935284-A1 HETEROCYCLIC NUCLEAR HORMONE RECEPTOR MODULATORS AbbVie Inc. (US) 2015-10-28 EP disclosed
WO-2014094357-A1 HETEROCYCLIC NUCLEAR HORMONE RECEPTOR MODULATORS ABBVIE INC. (US) 2014-06-26 WO disclosed